Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Home Newsfeeds GT Biopharma Q2 EPS $(0.10) Up From $(0.15) YoY

GT Biopharma Q2 EPS $(0.10) Up From $(0.15) YoY

GT Biopharma (NASDAQ:GTBP) reported quarterly losses of $(0.10) per share. This is a 33.33 percent increase over losses of $(0.15) per share from the same period last year.

byBenzinga Newsdesk

August 11, 2022

1 minute read

GT Biopharma (NASDAQ:GTBP) reported quarterly losses of $(0.10) per share. This is a 33.33 percent increase over losses of $(0.15) per share from the same period last year.

Earnings

Recap: Centrus Energy Q4 Earnings

By Benzinga Insights

February 8, 5:55 PM

Centrus Energy (AMEX:LEU) reported its Q4 earnings results on Thursday, February 8, 2024 at 04:30 PM. Here’s what…

LEU

Atlanta Fed President Bostic Says Expect U.S. GDP At 1% For 2023, “Pretty Slow”

By Benzinga Newsdesk

January 6, 12:25 PM

- Reuters

SPY

On January 12, Ault Alliance Announced The Board Approved A 1-For-25 Reverse Stock Split Of The Common Stock, Anticipates That Beginning With The Opening Of Trading On January 17, 2024

By Benzinga Newsdesk

January 16, 1:34 PM

Ault Alliance, Inc. (NYSE:AULT), a diversified holding company ("Ault Alliance," or the "Company"), announced today the voting results from the annual meeting of stockholders (the "Meeting") held today, January 12, 2024.

AULT